A Bibliometric Analysis and Visualization of Current Research Trends in Chinese Medicine for Osteosarcoma.
10.1007/s11655-020-3429-4
- Author:
Meng-Chen YIN
1
;
Hong-Shen WANG
1
;
Xi YANG
2
;
Chong-Qing XU
1
;
Tao WANG
1
;
Yin-Jie YAN
1
;
Zhao-Xiang FAN
1
;
Jun-Ming MA
1
;
Jie YE
1
;
Wen MO
3
Author Information
1. Department of Orthopaedics, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
2. Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
3. Department of Orthopaedics, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China. mw2218@126.com.
- Publication Type:Journal Article
- Keywords:
Chinese medicine;
bibliometric analysis;
osteosarcoma;
research trends;
visualization
- MeSH:
Bibliometrics;
China;
Humans;
Medicine, Chinese Traditional;
Osteosarcoma/therapy*;
Publications
- From:
Chinese journal of integrative medicine
2022;28(5):445-452
- CountryChina
- Language:English
-
Abstract:
BACKGROUND:To illustrate the research framework, overall knowledge structure, and development trends of Chinese medicine (CM) treatment for osteosarcoma (OS) by using a bibliometric analysis and newly developed visualization tools.
METHODS:Research datasets were acquired from the Web of Science (WOS) database from January 1, 1980 to September 30, 2019. VOS viewer and Citespace software was used to analyze the data and generate visualization knowledge maps. Annual trends of publications, distribution of institutes, distribution of journals, citation and H-index status, co-authorship status, research hotspots and co-citation status were analyzed.
RESULTS:A total of 223 publications in the WOS database met the requirement. The number of published articles showed a rise but the citation frequency and the H-index of China were relatively low. The cooperation between the countries, institutes and authors were relatively weak. Most publications were basic researches. Most of the previous researches focused on basic mechanisms of CM in treating OS, and therapy and improvement of dosage form may become a frontier in this research field.
CONCLUSIONS:Compared with other fields, the field of CM treatment for osteosarcome is still in infancy. The distribution of researches is imbalanced and cooperation between countries, institutions and authors remains to be strengthened. Furthermore, basic research occupies an absolute dominant position, and the exploration of the molecular mechanism of CM in preventing and treating OS may become a key point in the future.
